Opioids

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Receptors: Opioids bind to mu, kappa, and delta receptors in the central nervous system. The primary life-threatening pathophysiology is mu-receptor agonism in the medullary respiratory centers, which drastically blunts the hypercapnic drive.
• The Clinical Result: This binding directly drives profound, dose-dependent hypoventilation, hypercarbia, and eventually hypoxic cardiac arrest. Secondary effects include pupillary miosis, decreased gastrointestinal motility, and mild hypotension primarily driven by histamine release.
• The Withdrawal State: Chronic use downregulates endogenous opioid production. Abrupt cessation or administration of an antagonist unmasks massive sympathetic hyperactivity, presenting as severe autonomic arousal (tachycardia, hypertension, diaphoresis) and intense somatic distress.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Airway & Breathing First: Airway protection, oxygenation, and ventilation are the absolute cornerstones of management. If the patient is apneic, initiate bag-valve-mask (BVM) ventilation with 100% oxygen before focusing on antidotes.
• The Reversal Agent (Naloxone): Administer intravenous (IV), intramuscular (IM), or intranasal naloxone.
• Standard Adult Dosing: >20 kg: 2 mg IV/IO.
• Pediatric Dosing: <20 kg: 0.1 mg/kg IV/IO.
• Titration Note: Unregulated street fentanyl and synthetic opioids frequently require much higher doses of naloxone to achieve reversal. Titrate to adequate respiratory rate, not necessarily to full consciousness.
• Hypoglycemia Reversal: Obtain an immediate point-of-care capillary glucose, as hypoglycemia is the only consistent laboratory abnormality in opioid toxicity and can compound CNS depression.
• Active Withdrawal Management: For patients in active withdrawal, Buprenorphine is safe and highly recommended in the ED to reduce mortality. Administer an initial dose of 4 to 8 mg sublingually (SL). If buprenorphine is unavailable, clonidine can be used to suppress sympathetic hyperactivity.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• The "Can't-Miss" Mimics:
• Clonidine Toxicity: Presents nearly identically with miosis, bradycardia, hypotension, and lethargy.
• Sedative-Hypnotic/Benzodiazepine Overdose: Causes severe respiratory depression and coma, though typically presents with normal or mid-position pupils.
• Hypoglycemia: A rapidly reversible metabolic mimic of coma.
• Prioritized Diagnostic Workup:
• Co-ingestant Screening (Mandatory): Always draw quantitative serum acetaminophen and salicylate levels. Many prescription opioids are formulated as combination products (e.g., Percocet, Vicodin), and failing to check these levels can lead to missed hepatotoxicity.
• Serum Ethanol: Frequently co-ingested and compounds respiratory depression.
• Urine Drug Screens (UDS): Do NOT rely on UDS. A negative screen is notoriously unreliable (frequently missing synthetic fentanyl analogs) and should never deter a diagnosis of opioid intoxication when the clinical toxidrome is present.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The 12-Lead ECG Checklist: Essential for identifying specific opioid complications. Look explicitly for QRS widening (a classic sign of propoxyphene/norpropoxyphene toxicity causing sodium channel blockade) and QTc prolongation (classic for methadone toxicity).
• Chest Radiograph (CXR): If you auscultate pulmonary rales or the patient remains hypoxic after reversal, obtain a portable CXR to evaluate for non-cardiogenic pulmonary edema (acute lung injury).
• The Physical Exam Visuals: Fully undress the patient. Actively search for hidden fentanyl patches on all body parts, including mucous cavities, and assess muscle groups for early signs of compartment syndrome resulting from prolonged down-time.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The 4-Hour Observation Rule: Patients treated with naloxone for a presumed short-acting opioid overdose can be safely discharged after a 4-hour observation window if they remain asymptomatic with normal vital signs. Studies show delayed respiratory arrest after this 4-hour mark is exceptionally rare (0.1% - 0.6%).
• Clinical Opiate Withdrawal Scale (COWS): Used to stratify withdrawal severity and guide buprenorphine induction. A COWS score of $\ge$ 13 (Moderate-Severe) is the threshold to strongly consider starting with 8 mg of sublingual buprenorphine.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• The Urine Screen Pitfall: Pitfall: Discarding the diagnosis of opioid overdose because the rapid UDS is negative. Critical Action: Treat the patient based on the clinical toxidrome (miosis, respiratory rate <12, lethargy) and response to naloxone, regardless of UDS results.
• The Withdrawal Cognition Trap: Pitfall: Ascribing confusion or altered mental status to opioid withdrawal. Critical Action: Simple opioid withdrawal causes severe agitation, restlessness, and autonomic signs, but it does not alter cognition. If a withdrawing patient is confused, you must actively search for another etiology.
• The Lomotil Trap: Pitfall: Discharging a toddler who ingested a single diphenoxylate/atropine (Lomotil) tablet because they look fine at 2 hours. Critical Action: Asymptomatic pediatric patients with known Lomotil ingestion must be admitted for prolonged observation due to the delayed onset of deadly toxicity from its active metabolite.
• The Antagonist Trap: Pitfall: Using Nalmefene instead of naloxone. Critical Action: Avoid nalmefene; it is a long-acting opioid antagonist that will plunge the patient into prolonged, untreatable withdrawal.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzwords: "Respiratory rate < 12, miosis, lethargy" combined with "drug paraphernalia" or a "tourniquet." Exam Answer: Opioid intoxication.
• Buzzwords: "Opioid overdose" + "widened QRS complex on ECG." Exam Answer: Propoxyphene toxicity.
• Distractor: An exam question describes a patient in opioid withdrawal with severe confusion and asks for the next step. An option will suggest "Give buprenorphine for withdrawal." Correction: Confusion is NOT part of simple withdrawal; the correct answer will involve searching for an alternative cause of altered mental status.
• Distractor: "Order a urine drug screen to confirm the diagnosis." Correction: Diagnosis is clinical; the mandatory lab tests to order are acetaminophen and salicylate levels to rule out combo-pill co-ingestions.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Initial Resuscitation: "The patient presents with the classic opioid toxidrome of miosis and severe respiratory depression. My immediate priority is the airway. I will position the airway and initiate bag-valve-mask ventilation with 100% oxygen. Concurrently, I will administer IV naloxone, titrating up if this is a suspected synthetic fentanyl analog."
• The Diagnostic Workup: "I will not rely on a urine drug screen. Instead, I will immediately check a point-of-care capillary glucose to rule out hypoglycemia. Because many prescription opioids are combination pills, I am explicitly ordering serum acetaminophen and salicylate levels to prevent missing a delayed hepatotoxic or metabolic disaster."
• The Physical Exam & Disposition: "I will completely undress the patient to search for hidden fentanyl patches in skin folds or mucous cavities, and I will palpate all compartments to rule out crush injury and compartment syndrome from prolonged down-time. If the patient awakens and remains totally asymptomatic with normal vitals for 4 hours post-naloxone, I will medically clear them for discharge."